CytomX Therapeutics (CTMX) Non-Current Deffered Revenue (2014 - 2026)
CytomX Therapeutics (CTMX) posted Non-Current Deffered Revenue of $30.62 million for Q2 2026, up 199.0% from $10.24 million a year earlier.
CytomX Therapeutics (CTMX) Non-Current Deffered Revenue (2014 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics' Non-Current Deffered Revenue came in at $1.59 million, down 94.1% from FY2024.
- Annual Non-Current Deffered Revenue has declined for five consecutive years, with a five-year compound annual growth rate of -64.4% (FY2020 to FY2025).
- In prior years, CytomX Therapeutics' Non-Current Deffered Revenue was $26.86 million in FY2024 (-66.4%), $80.05 million in FY2023 (-55.5%), $180.06 million in FY2022 (-26.2%) and $243.94 million in FY2021 (-11.8%).
- The Q2 2026 figure stands as the highest quarterly Non-Current Deffered Revenue since Q3 2024.
- On a year-over-year basis, Non-Current Deffered Revenue increased in 1 of the last eight quarters, with an average decline of 44.3%.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q2 2026, with growth of 199.0%; the weakest was Q4 2025, with a decline of 94.1%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $979,000 (Q1 2026), $1.59 million (Q4 2025) and $5.54 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | CytomX Therapeutics | 592.69 Mn | -364.98 Mn | - | 30.62 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.62 Mn |
| Mar 31, 2026 | 979,000.00 |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 16.21 Mn |
| Dec 31, 2024 | 26.86 Mn |
| Sep 30, 2024 | 33.56 Mn |
| Jun 30, 2024 | 36.71 Mn |
| Mar 31, 2024 | 59.74 Mn |
| Dec 31, 2023 | 80.05 Mn |
| Sep 30, 2023 | 112.26 Mn |
| Jun 30, 2023 | 140.87 Mn |
| Mar 31, 2023 | 157.13 Mn |
| Dec 31, 2022 | 180.06 Mn |
| Sep 30, 2022 | 168.33 Mn |
| Jun 30, 2022 | 203.91 Mn |
| Mar 31, 2022 | 222.09 Mn |
| Dec 31, 2021 | 243.94 Mn |
| Sep 30, 2021 | 254.26 Mn |
CytomX Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();